Vanderbilt-Ingram Cancer Center

Cathy Eng, MD

Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships 

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.

color-enhanced cross section of tumor tissue

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study.
The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

VUMC hosts International Lung Cancer Consortium meeting 

The consortium is coordinated by the International Agency for Research on Cancer with the aim of sharing data from ongoing lung cancer case-control and cohort studies.

(iStock)

‘Off-the-shelf’ CAR-T therapy shows promise for relapsed/refractory multiple myeloma 

The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial.

DAISY Award spotlight: ‘She has been there so many times for my husband and me.’

Jenny Meier, RN, works in the Vanderbilt-Ingram Cancer Center. She is one of the latest DAISY Award winners at VUMC.

Clip in 4 the Cure was held at Geodis Park on Saturday, Sept. 14.

Clip In 4 the Cure

The high-energy fundraiser began in 2022 to raise money for cancer initiatives at Vanderbilt-Ingram Cancer Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt.

1 3 4 5 6 7 28